Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Symptom networks in patients with substance use disorders.
Rutten RJT, Broekman TG, Schippers GM, Schellekens AFA. Rutten RJT, et al. Among authors: schellekens afa. Drug Alcohol Depend. 2021 Dec 1;229(Pt B):109080. doi: 10.1016/j.drugalcdep.2021.109080. Epub 2021 Sep 29. Drug Alcohol Depend. 2021. PMID: 34634562
Substance Misuse Education for Physicians: Why Older People are Important.
De Jong CA, Goodair C, Crome I, Jokubonis D, El-Guebaly N, Dom G, Schellekens A, Broers B, Subata E, Welle-Strand GK, Luycks L, Wolters M, Schoof T. De Jong CA, et al. Yale J Biol Med. 2016 Mar 24;89(1):97-103. eCollection 2016 Mar. Yale J Biol Med. 2016. PMID: 27505022 Free PMC article. Review.
Psilocybin for treating substance use disorders?
de Veen BT, Schellekens AF, Verheij MM, Homberg JR. de Veen BT, et al. Expert Rev Neurother. 2017 Feb;17(2):203-212. doi: 10.1080/14737175.2016.1220834. Epub 2016 Aug 12. Expert Rev Neurother. 2017. PMID: 27684102 Review.
International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A; ICASA consensus group; Matthys F. Crunelle CL, et al. Eur Addict Res. 2018;24(1):43-51. doi: 10.1159/000487767. Epub 2018 Mar 6. Eur Addict Res. 2018. PMID: 29510390 Free PMC article.
Relating addiction and psychiatric disorders.
Vink JM, Schellekens A. Vink JM, et al. Science. 2018 Sep 28;361(6409):1323-1324. doi: 10.1126/science.aav3928. Science. 2018. PMID: 30262491 No abstract available.
Onset and Severity of Early Disruptive Behavioral Disorders in Treatment-Seeking Substance Use Disorder Patients with and without Attention-Deficit/Hyperactivity Disorder.
González RA, Vélez-Pastrana MC, Blankers M, Bäcker A, Konstenius M, Holtmann M, Levin FR, Noack M, Kaye S, Demetrovics Z, van de Glind G, van den Brink W, Schellekens A; ICASA Group. González RA, et al. Eur Addict Res. 2020;26(4-5):211-222. doi: 10.1159/000508653. Epub 2020 Jun 26. Eur Addict Res. 2020. PMID: 32594079
Effects of substance misuse and current family history of substance use disorder on brain structure in adolescents and young adults with attention-deficit/hyperactivity disorder.
Novi M, Paraskevopoulou M, Van Rooij D, Schene AH, Buitelaar JK, Schellekens AFA. Novi M, et al. Among authors: schellekens afa. Drug Alcohol Depend. 2021 Nov 1;228:109032. doi: 10.1016/j.drugalcdep.2021.109032. Epub 2021 Sep 2. Drug Alcohol Depend. 2021. PMID: 34555690 Free article.
156 results